Verastem Oncology (VSTM) Misses Q4 EPS by 50c
Verastem Oncology (NASDAQ: VSTM) reported Q4 EPS of ($0.50). Revenue for the quarter came in at $17.54 million.
For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.
Verastem Oncology (NASDAQ: VSTM) reported Q4 EPS of ($0.50). Revenue for the quarter came in at $17.54 million.
For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.